Search Results:

Predicting patient responses to COVID-19 immunotherapies

06 December 2022

According to data from a phase 2 trial, researchers have discovered inflammatory markers that may help identify COVID-19 patients who are more likely to react to treatments like the anti-cancer medicine pacritinib…

Keep up while the storm is raging

Norberto, a 23-year old white male in his third relapse of a B cell acute lymphoblastic leukemia (B-ALL) has been treated with an infusion of autologous CD19 Chimeric Antigen Receptor (CAR) T cells (CAR-T cells). Ten days later, he felt severe discomfort in the middle of the night…

IUIS Webinar: What cancer immunologists are doing about COVID-19 ?

14th May

Did you watch the IUIS Webinar : “What cancer immunologists are doing about COVID-19?” by Rachel Humphrey, a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. Highlights from her talk include: Intersection in advances in cancer and infectious diseases immunology…

COVID-19 – Cytokine storm syndromes and immunosuppression

25th March

Mehat, P. et al recently stated that there is accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have cytokine storm syndrome. Immunosuppression treatment could help severe COVID-19 patients.

A case of lymphadenopathy and night sweats

A 33 year old male presents with a one month history of a non-productive cough, fever, night sweats, malaise, abdominal pain and weight loss. History: Known HIV positive, Diagnosed 8 months previously but not on ARV’s. Past medical history: Nothing of significance

International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids FoundationStellenbosch University